Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.
作者信息
Fodor J G, Frohlich J J, Genest J J, McPherson P R
机构信息
Prevention and Rehabilitation Centre, University of Ottawa Heart Institute, Ont.
出版信息
CMAJ. 2000 May 16;162(10):1441-7.
Abstract
摘要
相似文献
1
2
[Controversies and advances in the treatment of hyperlipidemias].
Gac Med Mex. 1998 Mar-Apr;134(2):253-6.
3
Clinical practice guidelines for the management of dyslipidemia.血脂异常管理的临床实践指南。
Can J Cardiovasc Nurs. 2004;14(2):7-10.
4
[Dyslipidemias in the elderly].
Rev Med Brux. 2001 Sep;22(4):A338-40.
5
6
[Dyslipidemias].
Clin Ter. 2003 Jan-Feb;154(1):65-9.
7
8
[Dyslipidemias and cardiovascular diseases: towards a new perspective].[血脂异常与心血管疾病：迈向新视角]
Rev Med Suisse Romande. 2002 Oct;122(10):489-93.
9
[Dyslipidemia in diabetes mellitus].[糖尿病中的血脂异常]
Ned Tijdschr Geneeskd. 2001 Apr 21;145(16):769-74.
引用本文的文献
1
Cardiorespiratory fitness estimations and their ability to predict all-cause mortality in patients with cardiovascular disease.心血管疾病患者的心肺适能评估及其预测全因死亡率的能力。
Int J Cardiol Cardiovasc Risk Prev. 2022 Oct 23;15:200154. doi: 10.1016/j.ijcrp.2022.200154. eCollection 2022 Dec.
2
Effect of nutrition education and traditional game-based physical activity interventions, on lipid profile improvement in overweight and obese children in West Java Indonesia.营养教育和传统游戏式体育活动干预对印度尼西亚西爪哇超重和肥胖儿童血脂改善的影响。
Nutr Res Pract. 2021 Aug;15(4):479-491. doi: 10.4162/nrp.2021.15.4.479. Epub 2021 Feb 9.
3
Dyslipidaemia for patients with low-energy femoral neck fractures after the treatment of cancellous screws: a retrospective study with a 3-year minimum follow-up.松质骨螺钉治疗后低能量型股骨颈骨折患者的血脂异常：一项至少随访3年的回顾性研究
BMC Musculoskelet Disord. 2017 Nov 10;18(1):440. doi: 10.1186/s12891-017-1804-x.
4
Lipid-lowering treatment patterns in patients with new cardiovascular events - estimates from population-based register data in Sweden.新发心血管事件患者的降脂治疗模式——基于瑞典人群登记数据的估计
Int J Clin Pract. 2016 Mar;70(3):222-8. doi: 10.1111/ijcp.12769. Epub 2016 Jan 22.
5
Are the new guidelines for the use of lipid-lowering agents sound, and should their adoption be encouraged?降脂药物使用的新指南合理吗？是否应该鼓励采用这些指南？
Can J Hosp Pharm. 2014 May;67(3):246-9. doi: 10.4212/cjhp.v67i3.1363.
6
The Cardiovascular Intervention Improvement Telemedicine Study (CITIES): rationale for a tailored behavioral and educational pharmacist-administered intervention for achieving cardiovascular disease risk reduction.心血管介入改善远程医疗研究（CITIES）：一项由药剂师量身定制行为和教育干预措施以降低心血管疾病风险的研究原理
Telemed J E Health. 2014 Feb;20(2):135-43. doi: 10.1089/tmj.2013.0145. Epub 2013 Dec 4.
7
Contemporary management and attainment of cholesterol targets for patients with dyslipidemia in China.中国血脂异常患者的当代管理及胆固醇目标达标情况。
PLoS One. 2013 Apr 9;8(4):e47681. doi: 10.1371/journal.pone.0047681. Print 2013.
8
Extract of Wax Gourd Peel Prevents High-Fat Diet-Induced Hyperlipidemia in C57BL/6 Mice via the Inhibition of the PPARγ Pathway.南瓜皮提取物通过抑制 PPARγ 通路预防 C57BL/6 小鼠高脂饮食诱导的高血脂症。
Evid Based Complement Alternat Med. 2013;2013:342561. doi: 10.1155/2013/342561. Epub 2013 Feb 25.
9
Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.评估瑞舒伐他汀在预防主动脉瓣狭窄患者舒张功能障碍进展中的有效性：瑞舒伐他汀对主动脉瓣狭窄进展观察测量影响（ASTRONOMER）研究的一项子研究。
Cardiovasc Ultrasound. 2011 Feb 7;9(1):5. doi: 10.1186/1476-7120-9-5.
10
Achieving cholesterol targets by individualizing starting doses of statin according to baseline low-density lipoprotein cholesterol and coronary artery disease risk category: the CANadians Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (CanACTFAST) study.根据基线低密度脂蛋白胆固醇和冠状动脉疾病风险类别个体化起始剂量他汀类药物以实现胆固醇目标：阿托伐他汀分层滴定使加拿大快速实现胆固醇目标研究（CanACTFAST）。
Can J Cardiol. 2010 Feb;26(2):80-6. doi: 10.1016/s0828-282x(10)70003-9.
本文引用的文献
1
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.他汀类药物对冠心病风险的影响：随机对照试验的荟萃分析
JAMA. 1999;282(24):2340-6. doi: 10.1001/jama.282.24.2340.
2
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.使用多危险因素评估方程评估心血管风险：美国心脏协会和美国心脏病学会给医疗专业人员的声明
Circulation. 1999 Sep 28;100(13):1481-92. doi: 10.1161/01.cir.100.13.1481.
3
Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.脂蛋白（a）和载脂蛋白（a）表型在动脉粥样硬化形成中的作用：布伦瑞克研究的前瞻性结果。
Circulation. 1999 Sep 14;100(11):1154-60. doi: 10.1161/01.cir.100.11.1154.
4
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.在稳定型冠状动脉疾病中，强化降脂治疗与血管成形术的比较。阿托伐他汀与血运重建治疗研究组。
N Engl J Med. 1999 Jul 8;341(2):70-6. doi: 10.1056/NEJM199907083410202.
5
Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention.临床实践中冠心病的预防。欧洲及其他学会冠心病预防联合特别工作组第二次报告的建议
Eur Heart J. 1998 Oct;19(10):1434-503. doi: 10.1053/euhj.1998.1243.
6
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.2型糖尿病患者以及有和没有既往心肌梗死的非糖尿病患者的冠心病死亡率。
N Engl J Med. 1998 Jul 23;339(4):229-34. doi: 10.1056/NEJM199807233390404.
7
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.洛伐他汀对胆固醇水平正常的男性和女性急性冠脉事件的一级预防：空军/德州冠状动脉粥样硬化预防研究（AFCAPS/TexCAPS）的结果
JAMA. 1998 May 27;279(20):1615-22. doi: 10.1001/jama.279.20.1615.
8
Prediction of coronary heart disease using risk factor categories.使用风险因素类别预测冠心病。
Circulation. 1998 May 12;97(18):1837-47. doi: 10.1161/01.cir.97.18.1837.
9
10
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S).斯堪的纳维亚辛伐他汀生存研究（4S）中的脂蛋白变化与主要冠心病事件发生率的降低
Circulation. 1998 Apr 21;97(15):1453-60. doi: 10.1161/01.cir.97.15.1453.
Zotero 插件